 |
The new era of systems medicine and cancer networks |
|
|
|
45 - 50 |
|
| |
Breast cancer: Trastuzumab for HER2-positive patients and molecular systems approach |
|
|
|
51 - 54 |
|
| |
Challenges for personalized medicine: A 2020 vision |
|
|
|
55 - 59 |
|
| |
Advances in laparoscopic gastrectomy for early and advanced resectable gastric cancer |
|
|
|
60 - 64 |
|
| |
Endoscopic submucosal dissection for gastric tube cancer after esophagectomy |
|
|
|
65 - 67 |
|
| |
Challenges and expectations for novel biologics discovery in HER2-negative breast cancer |
|
|
|
68 - 69 |
|
|
Genetic geographical ancestry and breast cancer: Exploring potential phenotypic clinical differences in patients from Africa and Europe |
|
|
|
70 - 72 |
10.2122/gbc.2010.0125 |
| |
Decision-making treatment for early breast cancer and future perspectives omega replica watches |
|
|
|
73 - 82 |
|
